Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating and fatal motor neuron disease. Diagnosis typically occurs in the fifth decade of life and the disease progresses rapidly leading to death within ~ 2–5 years of symptomatic onset. There is no cure, and the few available treatments offer only a mod...

Descripción completa

Detalles Bibliográficos
Autores principales: McGurk, L., Mojsilovic-Petrovic, J., Van Deerlin, V. M., Shorter, J., Kalb, R. G., Lee, V. M., Trojanowski, J. Q., Lee, E. B., Bonini, N. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114235/
https://www.ncbi.nlm.nih.gov/pubmed/30157956
http://dx.doi.org/10.1186/s40478-018-0586-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114235/
https://www.ncbi.nlm.nih.gov/pubmed/30157956
http://dx.doi.org/10.1186/s40478-018-0586-1

Ejemplares similares